In the Salesforce vs. Veeva saga, the clock is ticking for drugmakers

The split between major customer relationship management providers Salesforce and Veeva is years away, but the pressure on pharma and biotech companies to consider which path they’ll take is nigh.

Since the divorce was announced in 2022, both Veeva and Salesforce have been busy tinkering with their offerings to appeal to drugmakers who must commit to one or the other by the official split in September 2030. Veeva released its Vault CRM Suite in April 2024, while Salesforce updated its Life Sciences Cloud this month with boosted AI.